Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Meridian Small Cap Growth Fund's investment thesis on Tandem Diabetes Care ($TNDM) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$TNDMNASDAQTandem Diabetes Care

NEUTRAL

Meridian Small Cap Growth Fund—TNDM

Fund Letter

Q2 2026

Published July 28, 2026

View Fund Profile

$16.31USD

-18.0% vs last month

$19.50Pitched

-16.4% since pitch

Market Cap$1.3B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

The Meridian Small Cap Growth Fund returned 21.54% in Q2 2026, trailing the Russell 2000 Growth Index's 25.71% return due to factor headwinds from its quality-oriented, lower-beta positioning during a risk-on rally that favored high-beta and high-momentum stocks. Stock selection contributed...

— Chad Meade

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $TNDM, and what else Meridian Small Cap Growth Fund is buying.

Other pitches on $TNDM

Other investors who've written on Tandem Diabetes Care

Meridian Small Cap Growth FundBULL

Pitched Mar 31, 2025

Tandem Diabetes Care is an automated insulin delivery technology provider poised for long-term growth in both Type 1 and Type 2 diabetes markets. Although near-term U.S....

View all $TNDM pitches →